Covisint Corp. (COVS) Tops Q4 EPS by 10c

Covisint Corp. (NASDAQ: COVS) reported Q4 EPS of ($0.01), $0.10 better than the analyst estimate of ($0.11). Revenue for the quarter came in at $20 million versus the consensus estimate of $21.05 million.

For earnings history and earnings-related data on Covisint Corp. (COVS) click here.

You May Also Be Interested In

• Nomura/Instinet Upgrades Genting Singapore (GENS:SP) (GIGNY) to Neutral
• 4D Molecular Therapeutics, Inc. (FDMT) Misses Q2 EPS by 3c
• LogicBio Therapeutics (LOGC) Misses Q2 EPS by 10c